Dr. Min-Shi Lee has more than 30 years experiences in vaccine research and development including 6 years R&D in USA vaccine company, and several national vaccine development projects of enterovirus, influenza H5N1, H7N9 and seasonal influenza. To strengthen and grow Taiwan’s vaccine business, Dr. Min-Shi Lee’s group has established a start-up company for developing bivalent enterovirus vaccines and seasonal influenza virus-like particle (VLP) vaccines and also expend to more diseases area through this innovative technology platforms.

• PhD, Oxford University, UK
• MPH, National Taiwan University
• Investigator, NHRI, Taiwan (2005~)
• Scientist, Aviron/Medimmune (1999~2005)
• NIPM (former CDC), Taiwan (1993~1998)
• >30 years for vaccine research including measles, JEV, influenza (FluMist licensed in USA) , PIV3, and EV71 (licensed in Taiwan)
• Built Asia-Pacific Network for Enterovirus Surveillance (APNES)